159 related articles for article (PubMed ID: 6780255)
1. IgG heavy chain allotypes (Gm) in autoimmune diseases.
Nakao Y; Matsumoto H; Miyazaki T; Nishitani H; Takatsuki K; Kasukawa R; Nakayama S; Izumi S; Fujita T; Tsuji K
Clin Exp Immunol; 1980 Oct; 42(1):20-6. PubMed ID: 6780255
[TBL] [Abstract][Full Text] [Related]
2. Gm and Km allotypes in autoimmune diseases.
Dugoujon JM; Guitard E; Senegas MT
G Ital Cardiol; 1992 Jan; 22(1):85-95. PubMed ID: 1624073
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin G heavy-chain allotypes as possible genetic markers for human cancer.
Nakao Y; Matsumoto H; Miyazaki T; Watanabe S; Mukojima T; Kawashima R; Fujita T; Tsuji K
J Natl Cancer Inst; 1981 Jul; 67(1):47-50. PubMed ID: 6788993
[TBL] [Abstract][Full Text] [Related]
4. The association of IgG heavy-chain allotypes (Gm) with Graves' disease in Hungary.
Kozma L; Stenszky V; Kraszits E; Balazs C; Farid NR
Exp Clin Immunogenet; 1985; 2(3):154-7. PubMed ID: 3939975
[TBL] [Abstract][Full Text] [Related]
5. Primary hepatocellular carcinoma and IgG heavy chain allotypes.
Nakao Y; Matsumoto H; Okubo A; Miyazaki T; Iwasaki Y; Okimoto K; Yoshiba A; Kumada H; Fujita T
Clin Exp Immunol; 1983 Jun; 52(3):493-8. PubMed ID: 6307557
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin allotypes (GM and KM) and their interactions with HLA antigens in autoimmune diseases: a review.
Dugoujon JM; Cambon-Thomsen A
Autoimmunity; 1995; 22(4):245-60. PubMed ID: 8781716
[TBL] [Abstract][Full Text] [Related]
7. Immunogenetics of Hashimoto's and Graves' diseases.
Tamai H; Uno H; Hirota Y; Matsubayashi S; Kuma K; Matsumoto H; Kumagai LF; Sasazuki T; Nagataki S
J Clin Endocrinol Metab; 1985 Jan; 60(1):62-6. PubMed ID: 3838076
[TBL] [Abstract][Full Text] [Related]
8. IgG heavy chain allotype (Gm), a genetic marker for human chromosome 14q32, and haematopoietic malignancies.
Nakao Y; Matsumoto H; Tsuji K; Miyazaki T; Masaoka T; Nakayama S; Kinoshita K; Shingami T; Matsui T; Fujita T
Clin Exp Immunol; 1984 Jun; 56(3):628-36. PubMed ID: 6430611
[TBL] [Abstract][Full Text] [Related]
9. IgG heavy-chain (Gm) allotypes in demyelinating polyneuropathy associated with MAG-binding monoclonal IgM autoantibodies.
Kahn SN; Pandey JP
Ann Neurol; 1987 May; 21(5):507-9. PubMed ID: 2438994
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases.
Ardesjö B; Hansson CM; Bruder CE; Rorsman F; Betterle C; Dumanski JP; Kämpe O; Ekwall O
J Autoimmun; 2008 Jun; 30(4):273-82. PubMed ID: 18242955
[TBL] [Abstract][Full Text] [Related]
11. A differential association of interferon-gamma high-producing allele T and low-producing allele A (+874 A/T) with Hashimoto's thyroiditis and Graves' disease.
Rekha PL; Ishaq M; Valluri V
Scand J Immunol; 2006 Oct; 64(4):438-43. PubMed ID: 16970687
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin allotypes and immunoreactivity in chronic liver disease.
Schmidt W; Königstedt B; Zipprich B; Scheibe E; Nilius R
Hepatogastroenterology; 1987 Oct; 34(5):206-11. PubMed ID: 3315922
[TBL] [Abstract][Full Text] [Related]
13. Genetic epidemiology of non-insulin-dependent diabetes mellitus (NIDDM) in north India: distribution of Gm and Km allotypes in 'Punjabis'.
Gill PS; Pandey JP; Blangero J; Corruccini RS; Gill IS
Dis Markers; 1990; 8(2):59-67. PubMed ID: 2387125
[TBL] [Abstract][Full Text] [Related]
14. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese.
Kamizono S; Hiromatsu Y; Seki N; Bednarczuk T; Matsumoto H; Kimura A; Itoh K
Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-64. PubMed ID: 10848881
[TBL] [Abstract][Full Text] [Related]
15. IgG heavy chain allotypes (Gm) in atrophic and goitrous thyroiditis.
Nakao Y; Matsumoto H; Miyazaki T; Farid NR
J Immunogenet; 1982 Oct; 9(5):311-6. PubMed ID: 7175201
[TBL] [Abstract][Full Text] [Related]
16. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
17. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
Molnár I; Bokk A
Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
[TBL] [Abstract][Full Text] [Related]
18. Gm allotypes in blacks with systemic lupus erythematosus.
Fedrick JA; Pandey JP; Chen Z; Fudenberg HH; Ainsworth SK; Dobson RL
Hum Immunol; 1983 Oct; 8(2):177-81. PubMed ID: 6643143
[TBL] [Abstract][Full Text] [Related]
19. Association of three systemic lupus erythematosus susceptibility factors, PD-1.3A, C4AQ0, and low levels of mannan-binding lectin, with autoimmune manifestations in Icelandic multicase systemic lupus erythematosus families.
Kristjansdottir H; Saevarsdottir S; Gröndal G; Alarcón-Riquelme ME; Erlendsson K; Valdimarsson H; Steinsson K
Arthritis Rheum; 2008 Dec; 58(12):3865-72. PubMed ID: 19035512
[TBL] [Abstract][Full Text] [Related]
20. Natural antibody status in patients with Hashimoto's thyroiditis.
Jasani B; Ternynck T; Lazarus JH; Phillips DI; Avrameas S; Parkes AB
J Clin Lab Immunol; 1999; 51(1):9-20. PubMed ID: 11424741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
